BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1840065)

  • 1. Speed of onset of action of the newer antidepressants--fluoxetine and bupropion.
    George MS; Lydiard RB
    Int Clin Psychopharmacol; 1991; 6(4):209-17. PubMed ID: 1840065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine.
    Coleman CC; King BR; Bolden-Watson C; Book MJ; Segraves RT; Richard N; Ascher J; Batey S; Jamerson B; Metz A
    Clin Ther; 2001 Jul; 23(7):1040-58. PubMed ID: 11519769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antidepressants versus imipramine in the treatment of major depression: a meta-analysis.
    Workman EA; Short DD
    J Clin Psychiatry; 1993 Jan; 54(1):5-12. PubMed ID: 8428898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder.
    Pearlstein TB; Stone AB; Lund SA; Scheft H; Zlotnick C; Brown WA
    J Clin Psychopharmacol; 1997 Aug; 17(4):261-6. PubMed ID: 9241004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of placebo-controlled trials with bupropion.
    Zung WW
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):104-14. PubMed ID: 6406436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new generation of antidepressants.
    Feighner JP
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):49-55. PubMed ID: 6222037
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
    Blier P; Ward HE; Tremblay P; Laberge L; Hébert C; Bergeron R
    Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of bupropion in tricyclic-resistant or intolerant patients.
    Stern WC; Harto-Truax N; Bauer N
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):148-52. PubMed ID: 6406447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
    Beasley CM; Dornseif BE; Bosomworth JC; Sayler ME; Rampey AH; Heiligenstein JH; Thompson VL; Murphy DJ; Masica DN
    BMJ; 1991 Sep; 303(6804):685-92. PubMed ID: 1833012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of bupropion and amitriptyline in depressed outpatients.
    Mendels J; Amin MM; Chouinard G; Cooper AJ; Miles JE; Remick RA; Saxena B; Secunda SK; Singh AN
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):118-20. PubMed ID: 6406439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind study of bupropion and placebo in depression.
    Feighner JP; Meredith CH; Stern WC; Hendrickson G; Miller LL
    Am J Psychiatry; 1984 Apr; 141(4):525-9. PubMed ID: 6422779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of bupropion in elderly patients: preliminary observations.
    Kane JM; Cole K; Sarantakos S; Howard A; Borenstein M
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):134-6. PubMed ID: 6406442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining antidepressant medications: a good idea?
    Rush AJ
    Am J Psychiatry; 2010 Mar; 167(3):241-3. PubMed ID: 20194484
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical profile of the novel antidepressant bupropion.
    Stern WC; Harto-Truax N; Rogers J; Miller L
    Adv Biochem Psychopharmacol; 1982; 32():21-34. PubMed ID: 6807060
    [No Abstract]   [Full Text] [Related]  

  • 17. Antidepressant response and plasma concentrations of bupropion.
    Preskorn SH
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):137-9. PubMed ID: 6406443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the safety and efficacy of bupropion in depression.
    Halaris AE; Stern WC; Van Wyck Fleet J; Reno RM
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):101-3. PubMed ID: 6406435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.
    Kavoussi RJ; Segraves RT; Hughes AR; Ascher JA; Johnston JA
    J Clin Psychiatry; 1997 Dec; 58(12):532-7. PubMed ID: 9448656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.
    Emslie GJ; Rush AJ; Weinberg WA; Kowatch RA; Hughes CW; Carmody T; Rintelmann J
    Arch Gen Psychiatry; 1997 Nov; 54(11):1031-7. PubMed ID: 9366660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.